Viatris (VTRS) EBT (QoQ) (2020 - 2026)
Powered by 
Analysis
Viatris (VTRS) EBT (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.57 Bn | 38.91 Bn | 2.15 Bn |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 406.25 Mn | 365.00 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74.12% |
| Mar 31, 2026 | 27.90% |
| Dec 31, 2025 | -4,241.77% |
| Sep 30, 2025 | 96.36% |
| Jun 30, 2025 | 92.99% |
| Mar 31, 2025 | -488.22% |
| Dec 31, 2024 | -681.77% |
| Sep 30, 2024 | 123.10% |
| Jun 30, 2024 | -291.50% |
| Mar 31, 2024 | 123.93% |
| Dec 31, 2023 | -312.58% |
| Sep 30, 2023 | 20.78% |
| Jun 30, 2023 | 3.19% |
| Mar 31, 2023 | -78.03% |
| Dec 31, 2022 | 243.60% |
| Sep 30, 2022 | 9.81% |
| Jun 30, 2022 | -26.20% |
| Mar 31, 2022 | 358.71% |
| Dec 31, 2021 | -202.00% |
| Sep 30, 2021 | 191.24% |